Literature DB >> 15096408

Acute unilateral visual loss as the first symptom of cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy.

Alessandra Rufa1, Nicola De Stefano, Maria Teresa Dotti, Silvia Bianchi, Francesco Sicurelli, Maria Laura Stromillo, Bruno D'Aniello, Antonio Federico.   

Abstract

BACKGROUND: Although cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) is considered a cerebrovascular disorder with almost exclusively neurological symptoms, the arteriopathy is generalized and involves choroidal and retinal vasculature as demonstrated by fluorescein angiographic and ocular electrophysiological abnormalities. The occurrence of acute visual loss due to nonarteritic anterior ischemic optic neuropathy (NAION) has not previously been reported in CADASIL.
OBJECTIVE: To describe acute visual loss due to NAION as a possible manifestation of CADASIL. PATIENTS AND METHODS: The patient was a 60-year-old man with subcortical diffuse leukoencephalopathy, multi-infarct dementia, tetraparesis, visual loss, and a family history of stroke. We performed clinical and neuro-ophthalmological evaluation, electrophysiological assessment, brain magnetic resonance imaging, and genetic screening for mutations or small deletions of the Notch3 gene, (causing CADASIL).
RESULTS: The patient's first symptom was acute visual loss in the right eye due to NAION at age 27 years, in absence of the common cardiovascular risk factors and before any neurological impairment. The patient was reevaluated at age 60 years, and neuro-ophthalmological examination showed optic disc atrophy in the right eye with arteriolar narrowing and a reduction in visual acuity in the left eye. Fluorescein angiography of the right eye showed evidence of persistent peripapillary hypofluorescence with a retinal pigment epithelial windows defect in the inferior temporal area. Pattern reversal visual evoked potentials were abolished in the right eye. The P100 latency of the left eye was delayed and reduced in amplitude. The diagnosis of CADASIL was confirmed by molecular analysis (heterozygotes for the C406T mutation on exon 3 of the Notch3 gene). There was a family history of cerebrovascular disorders and ocular impairment.
CONCLUSIONS: Visual loss due to transient or stable ischemic events involving the optic nerve head should be considered in the CADASIL phenotype. The possibility of CADASIL should also be evaluated in patients with NAION who do not have cardiovascular risk factors but do have a family history of stroke.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15096408     DOI: 10.1001/archneur.61.4.577

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


  9 in total

1.  High frequency of exon 10 mutations in the NOTCH3 gene in Italian CADASIL families: phenotypic peculiarities.

Authors:  S Bianchi; A Rufa; M Ragno; C D'Eramo; F Pescini; L Pantoni; A Cappelli; A Perretti; E Zicari; P Zolo; D Inzitari; M T Dotti; A Federico
Journal:  J Neurol       Date:  2010-02-19       Impact factor: 4.849

2.  Vitreous haemorrhage and ischemic retinopathy in a patient with CADASIL.

Authors:  Manon Elena Owen; Thyge Peter Enevoldson; Heinrich Heimann
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2012-10-13       Impact factor: 3.117

3.  First report of a pathogenic mutation on exon 24 of the NOTCH3 gene in a CADASIL family.

Authors:  Raffaella Valenti; Silvia Bianchi; Francesca Pescini; Camilla D'Eramo; Domenico Inzitari; Maria Teresa Dotti; Leonardo Pantoni
Journal:  J Neurol       Date:  2011-03-16       Impact factor: 4.849

Review 4.  Diagnostic criteria for CADASIL in the International Classification of Headache Disorders (ICHD-II): are they appropriate?

Authors:  Simona Sacco; Diana Degan; Antonio Carolei
Journal:  J Headache Pain       Date:  2010-03-12       Impact factor: 7.277

Review 5.  Neuropsychiatric manifestations in CADASIL.

Authors:  Hugues Chabriat; Marie-Germaine Bousser
Journal:  Dialogues Clin Neurosci       Date:  2007       Impact factor: 5.986

6.  Identification of a known mutation in Notch 3 in familiar CADASIL in China.

Authors:  Zhen-Xuan Tan; Fei-Feng Li; You-Yang Qu; Ji Liu; Gui-Rong Liu; Jin Zhou; Yu-Lan Zhu; Shu-Lin Liu
Journal:  PLoS One       Date:  2012-05-18       Impact factor: 3.240

Review 7.  Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy (CADASIL) as a model of small vessel disease: update on clinical, diagnostic, and management aspects.

Authors:  Ilaria Di Donato; Silvia Bianchi; Nicola De Stefano; Martin Dichgans; Maria Teresa Dotti; Marco Duering; Eric Jouvent; Amos D Korczyn; Saskia A J Lesnik-Oberstein; Alessandro Malandrini; Hugh S Markus; Leonardo Pantoni; Silvana Penco; Alessandra Rufa; Osman Sinanović; Dragan Stojanov; Antonio Federico
Journal:  BMC Med       Date:  2017-02-24       Impact factor: 8.775

Review 8.  Vascular Dementia and Underlying Sex Differences.

Authors:  Firoz Akhter; Alicia Persaud; Younis Zaokari; Zhen Zhao; Donghui Zhu
Journal:  Front Aging Neurosci       Date:  2021-09-08       Impact factor: 5.750

Review 9.  The pericyte: A critical cell in the pathogenesis of CADASIL.

Authors:  Marie-Magdeleine Ruchoux; Raj N Kalaria; Gustavo C Román
Journal:  Cereb Circ Cogn Behav       Date:  2021
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.